Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials

D M Longo, G T Generaux, A Bengry-Howell, S Q Siler, Daniel Antoine, D Button, J.A. Caggiano, Jonathan A Eisen, J Iaci, R Stanulis, T Parry, M Mosedale, P B Watkins

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials'. Together they form a unique fingerprint.

Medicine & Life Sciences